Coronary artery stents: advances in technology

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Biomedical Engineering

Background:

• Percutaneous coronary intervention (PCI) has transformed coronary artery disease management since the 1970s.
• Intracoronary stents, including bare metal (BMS) and drug-eluting stents (DES), have improved PCI efficacy and safety.
• Continuous innovation in stent technology aims to enhance patient outcomes and reduce healthcare costs.

Purpose of the Study:

• To review the evolution and comparative efficacy of different stent classes (BMS vs. DES) in coronary revascularization.
• To describe current stent delivery systems and emerging technologies like bioresorbable stents.
• To highlight the advancements in reducing restenosis, stent thrombosis, and recurrent myocardial infarction.

Main Methods:

• Evidence review of large clinical trial data comparing balloon angioplasty, BMS, and DES.
• Analysis of outcomes including restenosis, stent thrombosis, and myocardial infarction rates.
• Overview of technological developments in stent design and delivery systems.

Main Results:

• Latest generation drug-eluting stents (DES) demonstrate superior outcomes compared to balloon angioplasty and bare metal stents (BMS).
• DES achieve the lowest rates of restenosis, stent thrombosis, and recurrent myocardial infarction.
• New stent technologies, such as bioresorbable stents, show promise for further improvements.

Conclusions:

• Drug-eluting stents represent a significant advancement in coronary artery disease treatment, offering improved safety and efficacy.
• Ongoing research into novel stent technologies and delivery systems is crucial for optimizing patient outcomes and reducing long-term costs associated with recurrent coronary events.